EGF and breast carcinoma: The EGF secreted by the TAMs activates the EGFR/ STAT3/SOX‐2 paracrine pathway in the breast cancer, resulting in increased SOX‐2 expression, which in turn enhances the CSC phenotype in the tumor cells.38